Pharmaceutical Companies Face Challenges in Generating AI Applications and Knowledge Management Free Whitepaper Available

Fun Reed Corporation (HQ: Toshima-ku, Tokyo; President: Keiichi Kobayashi; hereafter "Fanreed") has prepared and released a white paper free of charge based on the content of a roundtable discussion held on December 19, 2024, with the participation of pharmaceutical companies, which outlines issues related to knowledge management that have emerged in the field and the direction of solutions that utilize generative AI and other technologies. The white paper is available free of charge.

In this round-table discussion, the participants, who are in charge of "quality control," "development and regulatory affairs," and "IT" in the pharmaceutical industry, had a lively discussion about the issues they are facing in their respective fields and their approaches to knowledge sharing and AI generation.

This white paper consists of the "Quality Management", "Development and Regulatory Affairs", and "IT" sections, which were the themes of the above discussions.

They are intended to support the advancement of knowledge management throughout the industry, and are packed with practical tips for companies and parties involved in the pharmaceutical industry.

The white paper, "Knowledge Management Issues and Solutions for Pharmaceutical Companies," can be downloaded from the following URL

Quality Control: https://www.stiv.jp/download/003/

Development and Regulatory Affairs: https://www.stiv.jp/download/004/

IT: https://www.stiv.jp/download/005/

White paper "Knowledge Management Challenges and Solutions for Pharmaceutical Companies

White Paper Summary: Knowledge Management Challenges and Solutions for Pharmaceutical Companies

Quality Control

The main theme of this white paper is to improve the efficiency of information management in the quality department, such as GMP compliance and digitization of paper documents.

GMP compliance and acquisition of regulatory information

Improvement of data management and searchability

Automation from document search to creation

Integration of knowledge and education

Digitization of paper documents

Development and Regulatory Affairs

The main themes are selection of knowledge and utilization of RAG (Retrieval-Augmented Generation).

What is the knowledge that should be shared in the first place?

Current status and issues in data organization

How to deal with output accuracy and RAG

How to proceed with RAG system implementation

More advanced use cases

IT section

The main themes of the IT section are internal coordination and security environment for the introduction of generative AI.

How to start using generative AI

Creating a secure environment for multiple departments

Approaches to internal conservatives for AI implementation

Fanreed Inc. will continue to provide information and solutions that contribute to solving issues in the pharmaceutical industry.

Fanreed's "STiV" website, a platform for the utilization of generative AI for the pharmaceutical industry

https://www.stiv.jp/

Fanreed Corporation Company Profile

Established in 2013, Fanreed is a consolidated subsidiary of Taiyo Holdings Corporation (listed on TSE Prime), and is engaged in services that propose new ways of IT, such as DX promotion, smart agriculture, and smart factories.

President and Representative Director: Keiichi Kobayashi

Establishment: March 26, 2013

Location: Metropolitan Plaza Bldg. 15F, 1-11-1 Nishi-Ikebukuro, Toshima-ku, Tokyo

Company HP ： https://www.funlead.co.jp/